CPI, jobless claims, and Philly Fed data headline Thursday’s economic events

Earnings season continues, below we highlight companies expected to report earnings the next trading day so you can prepare for the market movements. Leading the action are some heavyweight names across various sectors, with Nike, FedEx, Accenture, Cintas, and Heico headlining Thursday’s earnings calendar, offering investors crucial insights into consumer spending, logistics, consulting services, and industrial performance.

Earnings Before the Open:

• Accenture Ltd (ACN): EPS estimate of $3.74 on revenue of $18.51B

• Cintas Corp (CTAS): EPS estimate of $1.2 on revenue of $2.77B

• Dardem Rest (DRI): EPS estimate of $2.11 on revenue of $3.07B

• CarMax Inc (KMX): EPS estimate of $0.3652 on revenue of $5.69B

• FactSet Research Systems Inc (FDS): EPS estimate of $4.35 on revenue of $599.98M

• Innovative Soluti (ISSC): EPS estimate of $0.09 on revenue of $18.11M

Earnings After the Close:

• Nike (NKE): EPS estimate of $0.3741 on revenue of $12.2B

• FedEx Corp (FDX): EPS estimate of $4.11 on revenue of $22.78B

• Heico Corp (HEI): EPS estimate of $1.21 on revenue of $1.17B

• Heico Corp A (HEIa): EPS estimate of $1.21 on revenue of $1.17B

• KB Home (KBH): EPS estimate of $1.79 on revenue of $1.66B

• Research In Motion Ltd (BB): EPS estimate of $0.035 on revenue of $135.6M

• Mission Produce Inc (AVO): EPS estimate of $0.195 on revenue of $314.65M

• Scholastic Corp (SCHL): EPS estimate of $2.07 on revenue of $556.72M

• Nano Nuclear Energy (NNE): EPS estimate of -$0.29 on revenue not available

• Bridgeline Digita (BLIN): EPS estimate of -$0.04 on revenue of $3.94M

Be sure to check back daily for updates and insights into the earnings season and access real-time results at Investing.com’s Earnings Calendar and Headlines section. Do you want to trade the earnings of the biggest companies like a pro? Then get InvestingPro now and access over 1000 metrics that will give you a significant advantage in the shark tank that is Wall Street. Click here.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Investing.com -- Morgan Stanley analysts see weight-loss drugs known as GLP-1s becoming one of the more important cross-sector debates for markets in the coming year, with implications that stretch well beyond pharmaceuticals.

The core question is not that whether these drugs work. That debate has largely been settled by strong demand and growing prescriptions. Instead, investors are now focused on how widely GLP-1s are adopted and how durable their impact on consumer behavior turns out to be.

Morgan Stanley flags healthcare and biopharma as the most direct beneficiaries, particularly companies involved in manufacturing, distribution and long-term treatment.

But the bigger uncertainty lies outside healthcare. As usage increases, analysts see potential ripple effects across food producers, restaurants and food retail, where changes in eating habits could slowly alter demand patterns.

The pace of that shift remains contested. One side of the debate argues that GLP-1 users will meaningfully cut calorie intake, leading to pressure on certain packaged food and fast-food categories. The other view is that the impact will be gradual and uneven, with consumers adapting what they eat rather than how much they spend overall.

Cost and access are another open question. Wider adoption depends on insurance coverage, pricing and how healthcare systems respond over time.

These factors will likely determine whether GLP-1s remain a niche product for some consumers or become a mainstream treatment with economy-wide effects.

For investors, the takeaway is that GLP-1s are evolving from a single-sector growth story into a broader structural theme.

The full impact may take years to show up, but expectations around food demand, consumer staples and healthcare spending are already starting to shift as the debate deepens.

Investing.com -- Andersen Group Inc. shares opened at $21 on Wednesday, jumping 31% above their initial public offering price of $16 per share in their New York Stock Exchange debut.

The tax and financial advisory services provider raised approximately $176 million in its IPO by selling 11 million shares of Class A common stock. The company is trading under the ticker symbol NYSE:ANDG.

Andersen has granted underwriters a 30-day option to purchase up to an additional 1.65 million shares at the initial offering price, less underwriting discounts and commissions.

Morgan Stanley and UBS Investment Bank are serving as lead book-running managers for the offering.

Andersen Group provides independent tax, valuation and financial advisory services to individuals, family offices, businesses and alternative investment funds across the United States. The company’s approach focuses on stewardship, transparency and high-quality service delivery.

The firm is part of a global platform spanning more than 180 countries, with member and collaborating firms providing tax, legal, valuation and consulting services through over 1,000 locations with more than 3,000 partners and 50,000 professionals worldwide.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Investing.com -- Amazon CEO Andy Jassy announced that the company has appointed Peter DeSantis to lead a new organization focused on its most expansive AI models, silicon development, and quantum computing.

DeSantis, a 27-year Amazon veteran, will report directly to Jassy in this new role. The organizational change aims to maximize the potential of several new technologies that will power Amazon’s future customer experiences.

"I cannot think of a better leader for this organization than Peter," Jassy stated in his announcement. He highlighted DeSantis’s extensive experience, including leading Amazon EC2 when it launched in 2006, spearheading the acquisition of Annapurna Labs in 2015, and managing AWS Infrastructure starting in 2016.

As part of the restructuring, Pieter Abbeel will lead Amazon’s frontier model research team in AGI (Artificial General Intelligence). Abbeel, described as "one of the world’s leading AI researchers," is the co-founder of Covariant, which pioneered the first commercial foundation model for robotics.

The announcement also revealed that Rohit Prasad, who has led the creation of Amazon Nova and the company’s AGI organization for the past two years, will leave Amazon at the end of this year. Prasad joined Amazon in 2013 during the early days of Alexa.

Under Prasad’s leadership, Amazon built twelve state-of-the-art foundation models with "industry-leading price-performance" that are now being used by tens of thousands of companies. Jassy expressed gratitude for Prasad’s contributions, technical vision, and leadership.

The leadership changes come shortly after Amazon launched its Nova 2 models at the recent re:Invent conference.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.